Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of antiparasitic and antimicrobial agents. Its structure supports activity against certain protozoal infections due to the presence of the nitrobenzimidazole core. Commonly employed in research settings to design new bioactive molecules, especially those targeting helminths and anaerobic pathogens. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates with improved metabolic stability and target selectivity.